๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Labeling of cysteine-containing peptides with 2-nitro-5-thiobenzoic acid

โœ Scribed by Mark X. Sliwkowski; Rodney L. Levine


Publisher
Elsevier Science
Year
1985
Tongue
English
Weight
447 KB
Volume
147
Category
Article
ISSN
0003-2697

No coin nor oath required. For personal study only.

โœฆ Synopsis


A method for specific labeling of cysteine-containing peptides has been developed using Ellman's reagent, 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB). Prior to cleavage with proteases or chemical reagents, proteins are reacted with DTNB, resulting in the formation of a mixed disulfide between the protein sulfhydryl group and 2-nitro-5-thiobenzoic acid (TNB). The formation of the mixed disulfide introduces a chromophore, with an absorbance peak at 328 nm. By monitoring peptide maps generated by HPLC at 210 and 328 nm, peptides containing cysteine residues are readily identified. The stability of the derivative was tested using glutathione-TNB as a model compound. Glutathione-TNB is stable to conditions used for CNBr cleavage, as well as those for tryptic cleavage. The TNB label may also increase the hydrophobicity of small peptides, which otherwise might not bind to reverse-phase matrices. This was the case for an oxidatively modified tetrapeptide isolated from Escherichia coli glutamine synthetase.


๐Ÿ“œ SIMILAR VOLUMES


Spectrophotometric determination of brom
โœ Shyun-long Yun; Clarence H. Suelter ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 276 KB

A spectrophotometric method for determination of bromopyruvate, based on the reaction with 2-nitro-S-thiobenzoic acid, is described. The reaction is complete in 30 min at room temperature in 0.1 M Tris-MES, 1 mM EDTA, pH 8.0. The method is sensitive to at least 1 x 10m5 M bromopyrnvate. Reagents are

Inhibition of cysteine proteases by pept
โœ Tanja Schirmeister ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 215 KB

Mammalian cysteine proteases of the papain superfamily are interesting targets for the development of new drugs against diseases connected to abnormal degradation of muscle or bone proteins. The high nucleophilicity of the active site of these proteases as well as the characteristics of the well-kno